Treasury yields shift amid new vaccine developments



[ad_1]

U.S. Treasury yields increased on Monday after an effective vaccine against AstraZeneca’s coronavirus was announced and is hopeful Americans could start being vaccinated in December.

The yield on the benchmark 10-year T-bill climbed to 0.849% at 5:07 a.m. ET, while the yield on the 30-year T-bill rose to 1.551%. Yields move inversely with prices.

Treasury yields rose as British pharmaceutical giant AstraZeneca announced on Monday that the coronavirus vaccine it had developed with the University of Oxford was on average 70% effective in protecting against Covid-19.

This follows similar promising news of effective vaccines from Pfizer and BioNTech, as well as Moderna.

Dr Moncef Slaoui, adviser on the US government’s “Operation Warp Speed” vaccination plan, told CNBC on Friday that people would be vaccinated within 24 hours of the Food and Drug Administration granting permissions to use the drug. emergency of a vaccine.

Slaoui said the United States would have “35 to 40 million doses” of a vaccine in December.

Confirmed coronavirus cases in the United States continue to climb to 12,247,488, according to data compiled by Johns Hopkins University.

October’s data from the Chicago Fed’s National Activity Index is due out at 10:30 a.m. ET on Monday, followed by November’s figures from the Markit Purchasing Managers Index at 11:45 a.m. ET.

Mary Daly, chairman of the San Francisco Federal Reserve, is due to speak at 3 p.m. ET and Chicago Fed Chairman Charles Evans is due to speak at 5 p.m. ET.

The auctions will take place Monday for $ 54 billion in 13-week notes and $ 51 billion in 26-week notes, as well as $ 56 billion in 2-year notes and $ 57 billion in 5-year notes.

[ad_2]

Source link